Drug Type Small molecule drug |
Synonyms ETHINYL ESTRADIOL/FERROUS FUMARATE/NORETHINDRONE, ETHINYL ESTRADIOL/FERROUS FUMARATE/NORETHINDRONE ACETATE, NORETHINDRONE ACETATE/ETHINYL ESTRADIOL/ETHINYL ESTRADIOL/FERROUS FUMARATE + [4] |
Target |
Mechanism ERs agonists(Estrogen receptors agonists), PR agonists(Progesterone receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (21 Feb 1978), |
Regulation- |
Molecular FormulaC20H24O2 |
InChIKeyBFPYWIDHMRZLRN-SLHNCBLASA-N |
CAS Registry57-63-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Contraception | US | 21 Feb 1978 |
Phase 3 | 938 | (24 Day NA/EE) | tmykpquxsi(pvqwvujedy) = mdspjzoarn dstosntaut (pvsyqdhval, hidocshlpq - cgpmoiqlaq) View more | - | 22 Mar 2011 | ||
(21 Day NA/EE) | tmykpquxsi(pvqwvujedy) = shyjstiejc dstosntaut (pvsyqdhval, tfhindmtpa - whiyyzmcuv) View more | ||||||
Phase 3 | 1,683 | Ethinyl Estradiol+Norethindrone | vlnuqeelbk(gphvskrsob) = gkifxavvpx vhlhieuxyc (hkjhrgsqyh, slvspuuhar - vmebyhadlm) View more | - | 22 Dec 2010 |